Abstract The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact
on patients with underlying malignancy. In this article, we summarize emerging data related …

Background At a global level, the COVID-19 disease outbreak has had a major impact on
health services and has induced disruption in routine care of health institutions, exposing …

Abstract Purpose of Review The outbreak of the novel coronavirus disease 2019 (COVID-
19) has emerged to be the biggest global health threat worldwide, which has now infected …

The coronavirus disease 2019 (COVID-19) pandemic has disrupted health care worldwide.
Patients with cancer seem to be particularly susceptible to morbidities and mortality from this …

People at high risk of morbidity and mortality from coronavirus disease 2019 (COVID-19),
including patients dealing with malignancies and patients on immunosuppressive …

The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide
threat and the major healthcare concern of the year 2020. Cancer research was directly …

ORIgINAl ARTIClE Wang, M. et al. KTE-X19 CAR T-cell therapy in relapsed or refractory
mantle-cell lymphoma. N. Engl. J. Med. 383, 1331–1342 (2020) 4.7% had severe clinical …

Abstract Coronavirus disease‐2019 (COVID‐19) has emerged as a novel infection which
has spread rapidly across the globe and currently presents a grave threat to the health of …

Background The relationship between cancer and COVID‐19 has been revealed during the
pandemic. Some anticancer treatments have been reported to have negative influences on …

Background: There is a global concern for the susceptibility of patients with cancer to the
adverse effects of novel coronavirus disease (COVID-19). Nevertheless, there is a signal of …